User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

Personal Finance News

RSS feedDisplaying articles 21 - 30 of most recent articles

MSA Safety's Dividend Announcement Will Tell You the Real Story Cold, hard cash tells a story that management may not be able to verbalize.
Fool.com | 9 hours, 18 minutes ago | comment? | recommend
Inside Valeant Pharmaceuticals' Bid for Allergan Heres why this pharmaceutical megamerger seems like a good deal for both companies.
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Why Shares of Penn National Gaming, Inc Plunged Today Is this meaningful or just another movement?
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Get Ready for E-Cigarettes to Light a Fire The FDA surprises the industry with level-headed proposed regulations that should benefit the e-cigarette segments of Lorillard, Reynolds American, and Altria -- though e-cig opponents are sure to be fired up.
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Earnings Roundup: Aetna, Inc. Continues the Medicaid Winning Steak Aetna (AET) joined United Healthcare (UNH) and Centene (CNC) in reporting robust first quarter sales and profit growth tied to rising Medicaid enrollment.
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Sarepta's Still a Gamble, Even With FDA Reversal Will Sarepta finally get approval for eteplirsen?
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
What You Should Know About Gilead's Sovaldi And Johnson & Johnson's Olysio Johnson & Johnson's (JNJ) Olysio and Gilead's (GILD) Sovaldi posted blockbuster run rates in the first quarter, but sales could soon be challenged by AbbVie (ABBV), Bristol-Myers (BMY), and Merck (MRK).
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Why Investors Should Love Biogen's Earnings Miss Biogen's shares slumbered through trading after the company's earnings release, but Tecfidera's impressive growth makes the future impressively bright for this biotech giant.
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
Illumina, Inc.: How the Market's Smartest Company is Living Up to the Hype Illumina won rave reviews for its innovative technology after making the $1,000 genome possible, but the company showed off its financial prowess in the first quarter.
Fool.com | 9 hours, 33 minutes ago | comment? | recommend
GameStop Continues to Walk in Blockbuster's Footsteps GameStop's attempts at reinventing its business bear a striking resemblance to the actions of Blockbuster.
Fool.com | 9 hours, 48 minutes ago | comment? | recommend